CRISPR SGE platform maps functional impact of 470 IL2RG variants in X-linked severe combined immunodeficiency

The source describes a CRISPR-targeted saturation genome editing (SGE) platform applied to primary human T cells. The scope involves functional mapping of IL2RG variants to assess their impact on X-linked severe combined immunodeficiency. The study analyzed 489 single nucleotide variants (SNVs) by comparing them against ClinVar-deposited benign or likely benign annotations and pathogenic or likely pathogenic annotations.

Key findings indicate that 470 variants were functionally defined, representing 470 of 489 total variants analyzed. The platform demonstrated 100% agreement with ClinVar benign annotations for 18 of 18 cases and 100% agreement with ClinVar pathogenic annotations for 42 of 42 cases. Additionally, the analysis discovered 90 novel loss-of-function mutations. The study validated a block in T-lymphocyte differentiation as a secondary outcome.

The publication does not report safety data, adverse events, or discontinuations. No limitations were explicitly listed by the authors. The practice relevance is not detailed in the provided text. The certainty of the functional impact mapping is presented based on the described platform performance without causal claims regarding clinical outcomes.